Astrazeneca (AZN) Advances But Underperforms Market: Key Facts

Yahoo Finance18:15 ET

AstraZeneca's (AZN) Tagrisso SNDA Gets FDA's Priority Tag

Yahoo FinanceJun 10 09:42 ET

GSK's RSV Vaccine Arexvy Gets FDA Nod for Adults 50-59 Years

Yahoo FinanceJun 10 08:54 ET

Centessa Pharma Hires CFO From Fusion After AstraZeneca Takeover

By Dean Seal Centessa Pharmaceuticals has hired the former chief financial officer of Fusion Pharmaceuticals after the latter company was acquired by AstraZeneca. The clinical-stage pharmaceutical c

WSJJun 10 07:37 ET

Berenberg Raises Price Target on AstraZeneca to GBP150 From GBP130, Cites More Confidence in Longer-Term Outlook, Keeps Buy Rating

Berenberg Raises Price Target on AstraZeneca to GBP150 From GBP130, Cites More Confidence in Longer-Term Outlook, Keeps Buy Rating.

MT NewswiresJun 10 06:39 ET

AstrraZeneca Announced Earlier Tagrisso Granted Priority Review In The US For Patients With Unresectable, Stage III EGFR-mutated Lung Cancer

AstraZeneca's supplemental New Drug Application (sNDA) for Tagrisso (osimertinib) has been accepted and granted Priority Review in the US for the treatment of adult patients with unresectable, Stage I

BenzingaJun 10 05:04 ET